Wednesday, July 4, 2012

US manufacturing shrinks for first time in 3 years

FILE- In this Friday, June 22, 2012, file photo, Tesla Model S frames are shown in the assembly area at the Tesla factory in Fremont, Calif. The Institute for Supply Management, a trade group of purchasing managers, reported Monday, July 2, 2012, that U.S. manufacturing is declining for the first time in nearly three years. Manufacturing activity fell in June to the lowest reading since July 2009. (AP Photo/Paul Sakuma, File)

FILE- In this Friday, June 22, 2012, file photo, Tesla Model S frames are shown in the assembly area at the Tesla factory in Fremont, Calif. The Institute for Supply Management, a trade group of purchasing managers, reported Monday, July 2, 2012, that U.S. manufacturing is declining for the first time in nearly three years. Manufacturing activity fell in June to the lowest reading since July 2009. (AP Photo/Paul Sakuma, File)

(AP) ? U.S. manufacturing shrank in June for the first time in nearly three years, adding to signs that economic growth is weakening.

Production and exports declined, and the number of new orders plunged, according to a monthly report released Monday by the Institute for Supply Management.

The slowdown comes as U.S. employers have scaled back hiring, consumers have turned more cautious, Europe faces a recession and manufacturing has slowed in big countries like China.

"This is not good," said Dan Greenhaus, chief economic strategist at BTIG, an institutional brokerage. Though the report "does not mean recession for the broader economy, it is still a terribly weak number."

The trade group of purchasing managers said its index of manufacturing activity fell to 49.7. That's down from 53.5 in May. And it's the lowest reading since July 2009, a month after the Great Recession officially ended. Readings below 50 indicate contraction.

Economists said the manufacturing figures were consistent with growth at an annual rate of 1.5 percent or less. That would be down from the January-March quarter's already tepid annual pace of 1.9 percent.

"Our forecast that the U.S. will grow by around 2 percent this year is now looking a bit optimistic," said Paul Dales, an economist at Capital Economics.

Stocks fell sharply after the report was released at 10 a.m. But investors appeared to shake off the bad manufacturing news by the end of the day. The Dow Jones industrial average recovered most of its early losses to close down just 8.7 points at 12,871. And broader indexes ended the day up.

Most economists aren't yet predicting another recession. Though the ISM report suggests manufacturing is contracting, it typically takes a sustained reading below 43 to signal the economy isn't growing.

Still, U.S. manufacturing, which has helped drive growth since the recession ended, is faltering at a precarious time.

Americans have pulled back on spending, which drives roughly 70 percent of growth. Europe's economy is likely in recession, which has hurt U.S. exports.

And China's manufacturing sector grew in June at its slowest pace in seven months, according to a survey released Sunday by the state-affiliated China Federation of Logistics and Purchasing.

Manufacturing will likely stay weak for the next few months. The ISM's gauge of new orders, a measure of future activity, plunged from 60.1 to 47.8. That's the first time it has fallen below 50 since April 2009, when the economy was still in recession.

Fewer new orders reflect growing concerns of businesses. In addition to slower global growth and less spending by U.S. consumers, many companies worry that U.S. lawmakers won't extend a package of tax cuts at the end of the year.

Bricklin Dwyer, an economist at BNP Paribas, said the uncertainty "has left businesses unwilling to invest."

A gauge of production in the ISM's survey fell to its lowest level in more than three years.

U.S. factories are also reporting less overseas demand. A measure of exports dropped to 47.5, its lowest level since April 2009.

A gauge of employment edged down but remained at a healthy level of 56.6. That suggests factories may still be adding jobs. Manufacturers have reported job gains for eight straight months.

Overall hiring has slowed sharply this spring. Employers added an average of only 73,000 jobs per month in April and May. That's much lower than the average of 226,000 added in the first three months of this year. The unemployment rate rose in May to 8.2 percent from 8.1 percent, the first increase in a year.

Worries about slowing job growth are outweighing the benefits of lower gas prices. A measure of consumer confidence fell in June for the fourth straight month.

Slower job growth and falling confidence are weighing on consumers' willingness to spend. Americans cut back on purchases of autos and other long-lasting factory goods in May, the government said Friday.

The sharp drop in U.S. factory activity overshadowed more positive news on housing.

Construction spending rose 0.9 percent in May from April, the Commerce Department said in a separate report Monday. It was the second straight monthly increase, even though the level of spending still isn't healthy.

The increase was driven by a surge in residential construction. Home sales are up from the same month last year. Mortgage rates are at the lowest levels in history. And prices have begun to stabilize in most markets.

The economy could also get a boost this summer from lower gas prices, which have tumbled more than 60 cents per gallon since peaking in April. The result is that consumers have more money to spend on other goods, from autos and furniture to electronics and vacations, that fuel economic growth.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/f70471f764144b2fab526d39972d37b3/Article_2012-07-02-Economy-Manufacturing/id-cbdd149e3b904313a965c55f2db4e98f

archer ibooks 2 ifl indoor football league newt gingrich wife callista rick perry

HTC One V now available from US Cellular

Android Central

U.S.Cellular customers can today pick up the HTC One V online and the device will be in-store starting Friday. While the Android handset may be a little overshadowed by its big brothers the One X and One S, the One V, as you'll recall from our review, does pack a pretty good punch for its price, which is $129.99 after a $100 mail-in rebate . Running Android 4.0 out of the box and complemented with the latest addition of Sense UI the One V is great looking and feels wonderful in the hand. It has the familiar 'chin' that we saw on the HTC Hero and Legend and whilst its 1GHz processor may not be as powerful as the One X and One S it certainly does a good job of making things run smoothly.

You can order the HTC One V online here and we have the full press release below for your viewing pleasure.

read more



Source: http://feedproxy.google.com/~r/androidcentral/~3/1YHgVpc3Z6I/story01.htm

catamount mike dantoni bulls heat goldman sachs brandon carr knicks coach encyclopedia britannica

Can congressional Republicans repeal Democratic health care law? (CNN)

Share With Friends: Share on FacebookTweet ThisPost to Google-BuzzSend on GmailPost to Linked-InSubscribe to This Feed | Rss To Twitter | Politics - Top Stories Stories, News Feeds and News via Feedzilla.

Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/236986044?client_source=feed&format=rss

dakota fanning casey anthony video diary lamarcus aldridge jeremy renner justin timberlake engaged bluefin tuna jonestown

Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug

Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug [ Back to EurekAlert! ] Public release date: 3-Jul-2012
[ | E-mail | Share Share ]

Contact: Julie Jette
jjette@tuftsmedicalcenter.org
617-636-3265
Tufts Medical Center

Boston, Mass. (July 3, 2012) Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.

"If our study works, it's potentially game-changing and could become part of the standard of care for patients being treated for coronary artery blockages," said Kuliopulos, Director of the Hemostasis and Thrombosis Lab at Tufts Medical Center.

Heart disease is the leading cause of death in the United States. The new approach could benefit patients who have had heart attacks or who need cardiac catheterization procedures to prop open clogged arteries with a stent. These patients face increased risk for blood clots that can cause heart attack and death. To reduce these risks, patients are currently treated with anti-clotting drugs, which increase their risk of life-threatening bleeding problems.

In a study to be published today in the journal Circulation, Tufts Medical Center researchers have discovered a mechanism to inhibit the ability of platelets to form clots without increasing the risk of bleeding. The new approach uses pepducins, which are able to travel inside cells to block receptors and inhibit molecular pathways that stimulate clot formation. By contrast, most approved drugs block receptors on the outside of cells. If successful, this new strategy could lead to an entirely new class of drugs.

The pepducin, PZ-128, inhibits PAR1, a platelet protein that stimulates clotting. When added to human blood samples, PZ-128 appears to inhibit clotting without affecting bleeding markers. It also clears out of the blood stream within hours, which should reduce the risk of long-term bleeding problems.

"Anytime you have a new molecule that exploits a novel mechanism of action, it's very exciting and the benefit to patients is potentially tremendous,'' said Carey Kimmelstiel, MD, Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Tufts Medical Center. "A new technology that can inhibit platelet function without increasing bleeding would be enormously powerful."

The next step is to evaluate the safety and effectiveness of the pepducin in humans. The five-year, $10 million NIH grant will fund the early stages of drug development. Researchers will first conduct a Phase I clinical trial in healthy human volunteers to determine whether the drug is safe. If successful, the grant will cover a multi-center Phase II clinical trial in 800 patients.

The research is the result of a long-term collaborative effort between laboratory scientists and the clinicians in the Cardiac Catheterization Laboratory at Tufts Medical Center.

"These exciting advances would not have been possible without this strong partnership," said Kuliopulos. "It is critical for researchers to have an understanding and appreciation of the clinical issues and practical matters concerning the real-world application of the drug."

###

About Tufts Medical Center and Floating Hospital for Children

Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Conveniently located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with seven community hospitals and with New England Quality Care Alliance, its community physicians' network. For more information, please visit www.tuftsmedicalcenter.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Tufts Medical Center researchers receive $10 million NIH grant to test blood clot prevention drug [ Back to EurekAlert! ] Public release date: 3-Jul-2012
[ | E-mail | Share Share ]

Contact: Julie Jette
jjette@tuftsmedicalcenter.org
617-636-3265
Tufts Medical Center

Boston, Mass. (July 3, 2012) Tufts Medical Center researchers are developing a first-of-its-kind drug to prevent deadly blood clots in heart disease patients, without the risk of serious bleeding associated with current medications. The National Heart, Lung, and Blood Institute of the National Institutes of Health has just awarded the team led by Athan Kuliopulos, MD, PhD, a $10 million grant to start testing a drug based on this novel technology.

"If our study works, it's potentially game-changing and could become part of the standard of care for patients being treated for coronary artery blockages," said Kuliopulos, Director of the Hemostasis and Thrombosis Lab at Tufts Medical Center.

Heart disease is the leading cause of death in the United States. The new approach could benefit patients who have had heart attacks or who need cardiac catheterization procedures to prop open clogged arteries with a stent. These patients face increased risk for blood clots that can cause heart attack and death. To reduce these risks, patients are currently treated with anti-clotting drugs, which increase their risk of life-threatening bleeding problems.

In a study to be published today in the journal Circulation, Tufts Medical Center researchers have discovered a mechanism to inhibit the ability of platelets to form clots without increasing the risk of bleeding. The new approach uses pepducins, which are able to travel inside cells to block receptors and inhibit molecular pathways that stimulate clot formation. By contrast, most approved drugs block receptors on the outside of cells. If successful, this new strategy could lead to an entirely new class of drugs.

The pepducin, PZ-128, inhibits PAR1, a platelet protein that stimulates clotting. When added to human blood samples, PZ-128 appears to inhibit clotting without affecting bleeding markers. It also clears out of the blood stream within hours, which should reduce the risk of long-term bleeding problems.

"Anytime you have a new molecule that exploits a novel mechanism of action, it's very exciting and the benefit to patients is potentially tremendous,'' said Carey Kimmelstiel, MD, Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Tufts Medical Center. "A new technology that can inhibit platelet function without increasing bleeding would be enormously powerful."

The next step is to evaluate the safety and effectiveness of the pepducin in humans. The five-year, $10 million NIH grant will fund the early stages of drug development. Researchers will first conduct a Phase I clinical trial in healthy human volunteers to determine whether the drug is safe. If successful, the grant will cover a multi-center Phase II clinical trial in 800 patients.

The research is the result of a long-term collaborative effort between laboratory scientists and the clinicians in the Cardiac Catheterization Laboratory at Tufts Medical Center.

"These exciting advances would not have been possible without this strong partnership," said Kuliopulos. "It is critical for researchers to have an understanding and appreciation of the clinical issues and practical matters concerning the real-world application of the drug."

###

About Tufts Medical Center and Floating Hospital for Children

Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Conveniently located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with seven community hospitals and with New England Quality Care Alliance, its community physicians' network. For more information, please visit www.tuftsmedicalcenter.org.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-07/tmc-tmc070212.php

kelis dick clark dies ibogaine jamie moyer bone cancer hossa the cell

Wednesday, June 20, 2012

Wii U tech won't circumvent used-game sales; first-party titles in ...

Nintendo hasn't incorporated any features in the Wii U to discourage used-game sales. Nintendo's Executive VP of Sales and Marketing, Scott Moffitt, told Gamespot at E3 that Nintendo isn't overtly concerned with combating used-game sales: "I don't know if we have a formal position on used-game sales. It is a reality in the marketplace," Moffitt said. "We're not trying to circumvent that." He didn't mention any specifics about online passes or DLC in Nintendo titles.

The Wii U's online strategy begins with the Miiverse, as Moffitt describes it, and Nintendo is focused on using its online capabilities to enhance social features, gameplay and "the connectedness gamers feel with one another."

Online multiplayer is a part of Nintendo's online strategy for Wii U, but not its entire focus. "Online multiplayer is one part of it, and certainly Wii U will enable the same online multiplayer features that have become popular in some of the competing consoles, but that's really one piece of the online gaming network," Moffitt said. "Our vision is broader."

Apparently Nintendo's vision isn't broad enough to include online multiplayer for Pikmin 3 ? though perhaps that's a case of not seeing the forest for the Pikmin.

The Wii U's output ranges from 480i to 1080p, and Moffitt said he thinks Nintendo's first-party titles will run at 1080p.

caucus results

Tuesday, June 19, 2012

The Champaign NewsGazette notes that thirteen NCAA FBS schools will have to pay out 272 million to coaches fired during aft...

SbB LIVE FROM LA (Jun 19, 2012 @ 7:17am ET)

11:00 AM: Grambling State University has approved a three-year contract for football coach Doug Williams. Williams had sued the school after he was promised a contract when he took the job in March 2011, but was told he would have to negotiate a new one.

9:00 PM: U.S. Marine Corporal Christopher Farias threw out the first pitch for Sunday's game at Dodger Stadium - and was surprised to find out that the catcher was his father, Lawrence.

8:45 PM: Video of the South Atlantic League holding its All-Star Game Home Run Derby on the deck of the U.S.S. Yorktown aircraft carrier in Charleston, South Carolina.

8:30 PM: A Czech basketball magazine asked Washington Wizards player Jan Vesely: "You're the only white playing for the Wizards. Is it odd for you?" Vesley's response: "No, it's not, we are all pros, nobody looks on the color of skin. The important thing is, we have to pull the same rope."

8:15 PM: An L.A. Kings fan (or perhaps two) took out classified ads in the Newark Star Ledger & Vancouver Province telling Devils & Canucks fans "Better luck next year".

8:00 PM: During a speech at a church event at San Diego's Qualcomm Stadium Sunday, New York Jets QB Tim Tebow said that Mel Gibson's movie "Braveheart" "had the biggest impact on my life."

7:45 PM: Former high school football star Brian Banks, who spent five years in prison on rape charges but was cleared when his alleged victim admitted she lied, has created a Kickstarter account to raise money to make a documentary about his experience.

7:30 PM: New England Patriots owner Robert Kraft was announced as one of this year's 18 new inductees into the Columbia University Athletics Hall of Fame.

7:15 PM: L.A. Kings Insider notes that the puck on the ice at the end of the Stanley Cup-clinching Game 6 was last seen in the glove of the New Jersey Devils' Patrik Elias.

7:00 PM: Arkansas Razorbacks offensive lineman Jason Peacock was sentenced to 10 days in jail & one year probation after pleading guilty to stealing another student's credit card.

6:45 PM: A man in Hopatcong, New Jersey called local police claiming he was the President & he wanted to talk to Jets QB Tim Tebow. When police went to look for the man, they found him his mother's bedroom closet under some pillows.

6:30 PM: Indianapolis Colts QB Andrew Luck & pro golfer Michelle Wie were among the 5,088 Stanford students who received their degrees in graduation ceremonies Sunday.

6:15 PM: Three soccer players for the Toronto FC MLS club were arrested on public intoxication charges after fighting outside a Houston nightclub early Monday morning.

6:00 PM: Ohio State released full details of Urban Meyer's contract, including an out clause that allows him to leave the job & still collect $1.5 million a year if more NCAA violations from the past pop up.

5:45 PM: The attorney for Tampa Bay Buccaneers cornerback Aqib Talib says the case against his client on assault with a deadly weapons charges has been dismissed.

michael dyer suspended new years ball drop new years rockin eve new york times square

Thursday, June 7, 2012

IT Security Blog. Mitigating Risks. Enabling Business Strategies. W ...

RiskAs a follow on to my blogpost on High Value Data Information Governance, I thought I would share some additional benefits that company's often realize when they have been able to effectively identify and assess risk for their most valuable information.

While this can be a daunting task for a company, the business benefits of doing so are numerous and span beyond simply "IT Security" into Enterprise Risk Management, Infrastructure Management,?Legal and other business areas.? Here are a just a few example of the reoccurring benefits that I see with my Fortune 500 clients:

Business Benefits:

? ?Improved collaboration and cross-functional decision making across business units.

?? Improved business engagement and buy-in to the company?s Information Security Program

?? Improved ties of security investments to any current or emerging Enterprise Risk Management efforts.

?? Data Protection investments are more effectively prioritized and deployed to protect the company?s most valuable information:

  1. BCP/DR ? prioritization of Business Continuity Plans/Disaster Recovery resources and efforts.
  2. Infrastructure Hardening - access controls, monitoring, administration, service levels, physical security, etc.
  3. Security Policy and Awareness efforts ? Increased control requirements for processes and systems that support High Value Information Assets and greater investments in Awareness activities for staff that make use of High Value Information.
  4. Security Technology Investments can be directed and used more wisely
  5. Focusing or redirecting SIEM, DLP, and other network based security controls to higher value assets and away from lower value.

?? Cost savings and/or Cost Avoidance by redirecting effort and energy away from less valuable information ? yes, this can and does happen. When a company?s leadership has agreed to what information is most valuable to protect, then it much easier to reduce control costs and accept risks associated with lower value information.

?? Vendor Management and 3rd Party Risk Management process improvement and decision making, based upon access to and transfer of high value information.

?? Reduced legal exposure via a documented, defensible, and agreed to prioritization of a company?s most valuate information assets and subsequent decisions in control investments. You are in a much better position or at least have a good ?1st Line of Defense?, if you have engaged a cross-functional group of business stakeholders that have agreed to what is most important and documented their decisions, than if you DON?T have this.? Even if you what you have is not perfect, at least you have demonstrated some initial due diligence?

If you would like some additional perspectives on High Value Information Assets, here is a good article of a security practioner?I work with, Tim Layton,?and what he refers to as Data Classication: Next Level.

I welcome your comments.

Mark Brooks

You can follow me on Twitter at https://twitter.com/#!/wmarkbrooks

You can connect with on LinkedIn at http://www.linkedin.com/in/wmarkbrooks

shirataki noodles john kerry prince fielder state of the union address 2012 obama state of the union 2012